Quarterly report pursuant to Section 13 or 15(d)

Stock Options, Warrants and Restricted Common Stock (Tables)

v3.20.2
Stock Options, Warrants and Restricted Common Stock (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation

The Company recognized total stock-based compensation expense during the three and nine months ended September 30, 2020 and 2019, granted under the Equity Plan, from the following categories (in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

2020

2019

2020

2019

Restricted stock awards under the Plan

$

467

$

81

$

2,848

$

373

Stock option awards under the Plan

-

-

-

58

Total stock-based compensation

$

467

$

81

$

2,848

$

431

Summary of Restricted Plan Activity

A summary of the Company’s unvested restricted common stock awards activity in the nine months ended September 30, 2020 is presented here:

Number of Shares

Weighted Average Grant-Date

Fair Value

Unvested at January 1, 2020

1,524,499

$

1.37

 

Vested

(1,850,965)

$

1.36

 

Granted

1,544,359

$

1.27

 

Unvested at September 30, 2020

1,217,893

$

1.27

 

Schedule of Changes in Outstanding Warrants

Following is a summary of outstanding warrants that were issued outside of the Equity Plan for the nine months ended September 30, 2020:

Shares

Underlying

Options/Warrants

Weighted

Average

Exercise

Price

Weighted

Average

Remaining

Contractual Term (Years)

Aggregate

Intrinsic Value

Outstanding at January 1, 2020

3,574,257

$

19.48

 

2.9

 

$

-

 

Exercised

(200,000

)

$

1.94

-

Forfeited

(20,000)

$

3.50

 

-

 

 

Outstanding at September 30, 2020

3,554,257

$

20.62

 

2.1

 

$

1,298,189

 

 

 

 

 

Exercisable at September 30, 2020

3,554,257

$

20.62

 

2.1

 

$

1,298,189